Literature DB >> 32103635

Effect of a mindfulness programme for long-term care residents with type 2 diabetes: A cluster randomised controlled trial measuring outcomes of glycaemic control, relocation stress and depression.

Shu-Ming Chen1, Huey-Shyan Lin2, John J Atherton3,4,5,6, Richard J MacIsaac7, Chiung-Jung Jo Wu8,9,10.   

Abstract

AIMS: The aim of this study was to determine physical, behavioural and psychosocial effects of a newly developed mindfulness programme for older adults with type 2 diabetes relocating to long-term care facility.
BACKGROUND: Taiwan is viewed as an "aged society" with significant proportion of the population living in a long-term care facility. Approximately one third of residents living in long-term care facilities have been diagnosed with type 2 diabetes, and disruption to management of their glycaemic levels is at risk for up to one year after relocating to a long-term care facility.
DESIGN: A cluster randomised controlled trial was used to examine the effects of a newly developed mindfulness programme on outcomes of glycaemic levels, relocation stress and depression.
METHODS: A total of 140 participants were recruited from six long-term care facilities in Southern Taiwan. A mindfulness programme was delivered over 9 weeks and consisted of meditations, education and exercise techniques that were delivered by a Registered Nurse trained in mindfulness strategies. Participants in the control group received routine care as provided in the facilities, including routine check-ups at diabetes clinics as necessary. Data were analysed by Johnson-Neyman technique and generalised estimating equations.
RESULTS: In total, 120 residents completed the study. The majority of patients were female (64.8%), and 83.5% of the sample were financially supported by their children. The results showed significant improvements in glycated haemoglobin (HbA1c), relocation stress (Wald χ2  = 78.91) and depression (Wald χ2  = 45.70) between groups. In the intervention group, the mean of HbA1c levels showed 16.4% reduction (Mean differences = 1.3; SD = 0.3). However, there were no significant differences in relocation stress and depression within groups.
CONCLUSION: The results provided positive effects of the mindfulness programme for older people with diabetes moving into long-term care facilities. The programme will assist in future planning for diabetes care in long-term care facilities. IMPLICATIONS FOR PRACTICE: To incorporate the mindfulness program into existing diabetes education programs for older people living in LTCFs. Further investigation on the sustainability of the mindfulness program is warranted.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  depression; diabetes; glycaemic control; long-term care; mindfulness; relocation stress

Year:  2020        PMID: 32103635     DOI: 10.1111/opn.12312

Source DB:  PubMed          Journal:  Int J Older People Nurs        ISSN: 1748-3735            Impact factor:   2.115


  4 in total

Review 1.  Utilization of Mind-Body Intervention for Integrative Health Care of COVID-19 Patients and Survivors.

Authors:  Hyun-Jeong Yang; Noriko Setou; Eugene Koh
Journal:  Int J Environ Res Public Health       Date:  2022-05-29       Impact factor: 4.614

2.  Impacts of mindfulness-based interventions in people undergoing hemodialysis: a systematic review.

Authors:  Bruno Nunes Razzera; Angélica Nickel Adamoli; Maitê Freitas Ranheiri; Margareth da Silva Oliveira; Ana Maria Pandolfo Feoli
Journal:  J Bras Nefrol       Date:  2022 Jan-Mar

3.  Influence of Self-Practice Oriented Teaching plus Psychological Intervention on Blood Glucose Level and Psychological State in Patients with Type 2 Diabetes Mellitus on Insulin Therapy.

Authors:  Xuefang Li; Juan Ge; Lei He
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-08       Impact factor: 2.650

4.  Effects of meditation on physiological and metabolic parameters in patients with type 2 diabetes mellitus "MindDM": study protocol for a randomized controlled trial.

Authors:  K P C Dalpatadu; P Galappatthy; P Katulanda; S Jayasinghe
Journal:  Trials       Date:  2022-09-30       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.